In one paragraphArticle in HemaSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
32 authors.
Saskia SonnenbergDepartment of Pediatric and Adolescent Medicine, Pediatric Hematology and Oncology, ALL-BFM Study Group University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany.
Nicole BodmerDepartment of Oncology University Children's Hospital Zurich Zurich Switzerland.
Gunnar CarioDepartment of Pediatric and Adolescent Medicine, Pediatric Hematology and Oncology, ALL-BFM Study Group University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany.ORCID https://orcid.org/0000-0001-8396-0127 Hester A de Groot-KrusemanPrincess Máxima Centre for Pediatric Oncology Utrecht The Netherlands.
Anja MörickeDepartment of Pediatric and Adolescent Medicine, Pediatric Hematology and Oncology, ALL-BFM Study Group University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany.
Hannah MuhleDepartment of Pediatric Hematology and Oncology University Medical Center Hamburg-Eppendorf Hamburg Germany.
Rob PietersPrincess Máxima Centre for Pediatric Oncology Utrecht The Netherlands.
Pierre RohrlichDepartment of Pediatric Onco-Hematology, Hospital l'Archet University of Côte d'Azur Nice France.
Martin SchrappeDepartment of Pediatric and Adolescent Medicine, Pediatric Hematology and Oncology, ALL-BFM Study Group University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany.ORCID https://orcid.org/0000-0003-0034-5845 Lucie SrámkováDepartment of Paediatric Haematology and Oncology, 2nd Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic.
Ajay VoraDepartment of Haematology Great Ormond Street Hospital London United Kingdom.
Emese ZsigraiDivision of Pediatric Hematology-Oncology, Department of Pediatric Hematology, Faculty of Medicine University of Debrecen Debrecen Hungary.
Arndt BorkhardtDepartment of Pediatric Oncology, Hematology and Clinical Immunology University Clinics Düsseldorf, Medical Faculty, Heinrich Heine University Düsseldorf Germany.ORCID https://orcid.org/0000-0002-6121-4737 International Berlin‐Frankfurt‐Münster (i‐BFM) Study Group
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID42757372
PMCPMC13585435
What OpenQuestion holds
Textmetadata
Read underepoch 390